摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

核丛青霉素 | 549-23-5

中文名称
核丛青霉素
中文别名
——
英文名称
sclerotiorin
英文别名
[(7R)-5-chloro-3-[(1E,3E,5S)-3,5-dimethylhepta-1,3-dienyl]-7-methyl-6,8-dioxoisochromen-7-yl] acetate
核丛青霉素化学式
CAS
549-23-5
化学式
C21H23ClO5
mdl
——
分子量
390.864
InChiKey
SWJLTKXURNHVHE-UPWXJBBJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    206-207℃
  • 比旋光度:
    [α]D20 +450~+550゜ (c=1, CHCl3)
  • 沸点:
    482.9±45.0 °C(Predicted)
  • 密度:
    1.23±0.1 g/cm3(Predicted)
  • 溶解度:
    DMF:30mg/mL; DMF:PBS(pH7.2)(1:2):0.3mg/ml; DMSO:20mg/mL;乙醇:3mg/mL

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    27
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    69.7
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 储存条件:
    -20°C,密闭保存,干燥环境

SDS

SDS:12ab341ba7bdffeb43e54d6b73205776
查看

制备方法与用途

sclerotiorin 是从青霉菌频繁种发酵液中提取的一种化合物,它能够强烈抑制人类多形核白细胞的5-脂氧合酶活性和人类血小板聚集。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    核丛青霉素 在 ammonium acetate 作用下, 以 四氢呋喃 为溶剂, 以100%的产率得到sclerotioramine
    参考文献:
    名称:
    Synthesis of the Azaphilones (+)-Sclerotiorin and (+)-8-O-Methylsclerotiorinamine Utilizing (+)-Sparteine Surrogates in Copper-Mediated Oxidative Dearomatization
    摘要:
    Enantioselective syntheses of the azaphilone natural products (+)-sclerotiorin and (+)-8-O-methylsclerotiorinamine that possess the natural R-configuration at the quaternary center are reported. The syntheses were accomplished using copper-mediated asymmetric dearomatization employing bis-y-oxo copper complexes prepared from readily available (+)-sparteine surrogates. Of note, site-selective O-methylation of a vinylogous pyridone was used to access the isoquinolin-6(7H)-one core of (+)-8-O-methylsclerotiorinamine.
    DOI:
    10.1021/jo102448n
  • 作为产物:
    描述:
    2,4-二甲氧基-3-甲基苯甲醛4-二甲氨基吡啶 、 bis-triphenylphosphine-palladium(II) chloride 、 N-氯代丁二酰亚胺copper(l) iodide正丁基锂 、 tetrakis(actonitrile)copper(I) hexafluorophosphate 、 1,2-二碘乙烷氧气三溴化硼potassium carbonateN,N,N'-三甲基乙二胺三乙胺二异丙胺N,N-二异丙基乙胺 、 tri tert-butylphosphoniumtetrafluoroborate 、 (1R,2S,9S)-11-ethyl-7,11-diazatricyclo[7.3.1.02,7]tridecane 作用下, 以 四氢呋喃二氯甲烷乙腈 为溶剂, 反应 62.58h, 生成 核丛青霉素
    参考文献:
    名称:
    Synthesis of the Azaphilones (+)-Sclerotiorin and (+)-8-O-Methylsclerotiorinamine Utilizing (+)-Sparteine Surrogates in Copper-Mediated Oxidative Dearomatization
    摘要:
    Enantioselective syntheses of the azaphilone natural products (+)-sclerotiorin and (+)-8-O-methylsclerotiorinamine that possess the natural R-configuration at the quaternary center are reported. The syntheses were accomplished using copper-mediated asymmetric dearomatization employing bis-y-oxo copper complexes prepared from readily available (+)-sparteine surrogates. Of note, site-selective O-methylation of a vinylogous pyridone was used to access the isoquinolin-6(7H)-one core of (+)-8-O-methylsclerotiorinamine.
    DOI:
    10.1021/jo102448n
点击查看最新优质反应信息

文献信息

  • Structure-specific Inhibition of Cholesteryl Ester Transfer Protein by Azaphilones.
    作者:HIROSHI TOMODA、CHIKAKO MATSUSHIMA、NORIKO TABATA、ICHIJI NAMATAME、HARUO TANAKA、MARK J. BAMBERGER、HIROYUKI ARAI、MASAYOSHI FUKAZAWA、KEIZO INOUE、SATOSHI OMURA
    DOI:10.7164/antibiotics.52.160
    日期:——
    The effect of thirteen different fungal azaphilones, which have a common 6-isochromane-like ring, was tested on cholesteryl ester transfer protein (CETP) activity in vitro. Chaetoviridin B showed the most potent inhibitory activity with an IC50 value of <6.2 μM, followed by sclerotiorin with an IC50 value of 19.4 μM. Rotiorin, chaetoviridin A and rubrorotiorin had moderate inhibitory activity (IC50; 30-40 μM), but others showed very weak or no inhibitory activity. The relationship between the structures and their inhibitory activity indicated that the presence of an electrophilic ketone(s) and/or enone(s) at both C-6 and C-8 positions in the isochromane-like ring is essential for eliciting CETP inhibitory activity. The transfer activity of both CE and TG was inhibited by sclerotiorin to approximately the same extent (IC50: 14.4 and 10.3 μM, respectively). A model of the reaction suggested that sclerotiorin reacts with a primary amine of amino acids such as lysine in the protein to form a covalent bond.
    测试了十三种不同的真菌吲哚酮(具有共同的6-异色满环)对体外胆固醇酯转移蛋白(CETP)活性的影响。Chaetoviridin B显示出最强的抑制活性,IC50值小于6.2 μM,其次是sclerotiorin,IC50值为19.4 μM。Rotiorin、chaetoviridin A和rubrorotiorin具有中等抑制活性(IC50; 30-40 μM),但其他化合物显示出非常弱或没有抑制活性。结构与其抑制活性之间的关系表明,在异色满环的C-6和C-8位置上存在亲电的酮或烯酮是引发CETP抑制活性的关键。Sclerotiorin对CE和TG的转移活性抑制程度大致相同(IC50分别为14.4和10.3 μM)。一种反应模型表明,sclerotiorin与蛋白质中赖氨酸等氨基酸的初级胺反应形成共价键。
  • Preparation, COX-2 Inhibition and Anticancer Activity of Sclerotiorin Derivatives
    作者:Tao Chen、Yun Huang、Junxian Hong、Xikang Wei、Fang Zeng、Jialin Li、Geting Ye、Jie Yuan、Yuhua Long
    DOI:10.3390/md19010012
    日期:——
    that anti-tumor agents with COX-2 inhibitory activity may benefit their anti-tumor efficiency. A series of sclerotiorin derivatives have been synthesized and screened for their cytotoxic activity against human lung cancer cells A549, breast cancer cells MDA-MB-435 using the MTT method. Among them, compounds 3, 7, 12, 13, 15, 17 showed good cytotoxic activity with IC50 values of 6.39, 9.20, 9.76, 7.75
    最新研究表明,具有COX-2抑制活性的抗肿瘤药可能会提高其抗肿瘤效果。合成了一系列巩膜硬化蛋白衍生物,并使用MTT方法筛选了它们对人肺癌细胞A549,乳腺癌细胞MDA-MB-435的细胞毒活性。其中,化合物3,7,12,13,15,17显示出良好的细胞毒活性与IC 50个分别为6.39,9.20,9.76,7.75,9.08,和8.18μM,值。另外,在体外测试了所有化合物的COX-2抑制活性。结果公开的化合物7,13,25硬化素和巩膜铁蛋白显示出对COX-2的中度到良好抑制,抑制率分别为58.7%,51.1%,66.1%和56.1%。值得注意的是,化合物3显示出与阳性对照消炎痛(78.9%)相当的抑制率(70.6%)。此外,通过预测它们的结合能,结合模式和在COX-2活性位点的最佳取向,使用分子对接来使硬化蛋白衍生物作为COX2抑制剂的潜力合理化。另外,已经解决了结构-活性关系(SARS)。
  • Sequential fungal fermentation-biotransformation process to produce a red pigment from sclerotiorin
    作者:Dhionne Corrêia Gomes、Jacqueline Aparecida Takahashi
    DOI:10.1016/j.foodchem.2016.04.057
    日期:2016.11
    fungus Penicillium sclerotiorum produces sclerotiorin, an orange compound closely related to the useful food coloring pigments produced by Monascus species. The high productivity, together with several biological activities reported for sclerotiorin highlights its potential application in food industry. In this work, sclerotiorin was obtained as the major metabolite produced in liquid fermentation by P
    真菌青霉菌核病产生sclerotiorin,橙色化合物密切相关的所产生的有用的食品着色颜料红曲霉物种。报道了巩膜铁蛋白的高生产率以及几种生物学活性,突显了其在食品工业中的潜在应用。在这项工作中,硬化菌素是菌核假单胞菌(P. sclerotiorum)在液体发酵中产生的主要代谢产物,占真菌干提取物的30%。通过使用球孢白僵菌的生物转化来完成硬化菌素的颜色调节生成产率为13.8%的红色衍生物。颜色改变是由吡喃环中的氮通过真菌介导的氧取代真菌引起的,从而改变了分子的发色团。使用重氮甲烷从硬皮草素合成衍生物1-甲基硬皮草素,并将其进料到球孢杆菌中。在这种情况下,C-1处的取代基避免了杂原子取代。目前获得的硬脂蛋白衍生物显示出作为食品着色剂的硬脂蛋白衍生物的巨大潜力。
  • Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma
    作者:Yang Hai、Jia-Jia Geng、Peng-Jie Li、Wei-Ping Ma、Cui-Fang Wang、Mei-Yan Wei、Xue-Mei Hou、Guang-Ying Chen、Yu-Cheng Gu、Ming Liu、Chang-Lun Shao
    DOI:10.1016/j.ejmech.2022.114166
    日期:2022.3
    proteins degradation through ubiquitin-proteasome system. Furthermore, 5 displayed significant in vivo anticancer effects in the xenograft models with decreasing the tumor mass by 52.5%. The safety evaluation was confirmed by acute toxicity subchronic toxicity tests, paraffin sections of mice organ and blood routine examination. Taken together, 5 can be developed as a potential therapeutic agent for hepatocellular
    肝细胞癌是最常见的原发性肝脏恶性肿瘤之一。在此,制备了一系列天然产物 ( + )-核盘菌素 ( 1) 的半合成衍生物 (2-30 ) ,并评估了对六种癌细胞系的细胞毒活性。其中,3和5是对人肝癌Bel-7402细胞系最有效的化合物,IC 50值分别为1.45和1.15  μ M。分子机制研究表明,5以半胱天冬酶依赖性方式破坏线粒体膜电位并诱导细胞凋亡。此外,5影响AKT和ERK信号通路,并通过泛素-蛋白酶体系统诱导AKT和ERK蛋白降解。此外,5在异种移植模型中显示出显着的体内抗癌作用,肿瘤质量减少了 52.5%。安全性评价通过急性毒性亚慢性毒性试验、小鼠器官石蜡切片和血常规检查证实。总之,5可被开发为肝细胞癌的潜在治疗剂。
  • Sclerotiorin衍生物及其制备方法与作为抗甲 型H1N1流感病毒剂的应用
    申请人:中国海洋大学
    公开号:CN105218447B
    公开(公告)日:2017-12-12
    一种Sclerotiorin衍生物及其制备方法与作为抗甲型H1N1流感病毒剂的应用,制备时先对真菌Penicillium sp.(TA33‑1)进行菌种培养,再对该真菌进行发酵培养,将所得菌丝体用氯仿‑甲醇混合液(1∶1)浸提3次减压浓缩后,用乙酸乙酯萃取3次得粗浸膏;依次进行正相硅胶柱层析、Sephadex LH‑20凝胶柱层析、HPLC高效液相色谱,得黄色粉末,即为(+)‑Sclerotiorin;在溶有(+)‑Sclerotiorin的二氯甲烷溶液中,加入有机伯胺和碳酸钾,反应后得到式I化合物。本发明提供一种抗甲型H1N1流感病毒剂,其特征在于以本发明的式I化合物或其药学上可接受的盐,用于治疗甲型H1N1病毒引起的流感。
查看更多

同类化合物

萘啶霉素 苯酚,4-(4-吗啉基磺酰)- 焦曲二醇 核丛青霉素 异色酮VI [(7R)-7-甲基-6,8-二氧代-3-[(E)-丙-1-烯基]异苯并吡喃-7-基]2,4-二羟基-6-甲基苯甲酸酯 (E,E,E)-(-)-7-(乙酰氧基)-3-(1,3,5-庚三烯基)-7-甲基-6H-2-苯并吡喃-6,8(7H)-二酮 (7S,8S)-5-氯-3-[(1E,3E)-3,5-二甲基庚-1,3-二烯基]-7,8-二羟基-7-甲基-8H-异苯并吡喃-6-酮 (7R,8R)-5-氯-3-[(1E,3E,5S)-3,5-二甲基庚-1,3-二烯-1-基]-7,8-二羟基-7-甲基-7,8-二氢-6H-异色烯-6-酮 Komaroviquinone entonaemin A 7-heptanoyloxy-3,7-dimethyl-7,8-dihydro-6H-isochromene-6,8-dione sclerketide B (+)-sclerotiorin 2-formyl-1,2-dihydro-6,7,8-trimethoxyisoquinoline Mitorubrinic acid, (S)- (E)-7-hydroxy-7-methyl-3-(prop-1-en-1-yl)-6H-isochromene-6,8(7H)-dione lunatoic acid A (3-Butyl-7-methyl-6,8-dioxoisochromen-7-yl) 6-chloropyridine-3-carboxylate (3-Cyclopropyl-7-methyl-6,8-dioxoisochromen-7-yl) 6-chloropyridine-3-carboxylate [3-(4-Cyanophenyl)-7-methyl-6,8-dioxoisochromen-7-yl] 6-chloropyridine-3-carboxylate (5-Acetyloxy-3-butyl-7-methyl-6,8-dioxoisochromen-7-yl) 6-chloropyridine-3-carboxylate 6-Chloronicotinic acid [6,8-diketo-7-methyl-3-(3-thienyl)isochromen-7-yl] ester Methyl 4-(7-methyl-6,8-dioxo-7-propanoyloxyisochromen-3-yl)butanoate [3-(4-Methoxy-4-oxidanylidene-butyl)-7-methyl-6,8-bis(oxidanylidene)isochromen-7-yl] 6-chloranylpyridine-3-carboxylate [3-(4-Methoxy-4-oxobutyl)-7-methyl-6,8-dioxoisochromen-7-yl] furan-2-carboxylate 4-(7-Hydrocinnamoyloxy-6,8-diketo-7-methyl-isochromen-3-yl)butyric acid methyl ester 4-O-[3-(4-cyanophenyl)-7-methyl-6,8-dioxoisochromen-7-yl] 1-O-methyl butanedioate 1-O-methyl 4-O-(7-methyl-6,8-dioxo-3-thiophen-3-ylisochromen-7-yl) butanedioate 4-O-(5-acetyloxy-3-butyl-7-methyl-6,8-dioxoisochromen-7-yl) 1-O-methyl butanedioate O4-[3-butyl-7-methyl-6,8-bis(oxidanylidene)isochromen-7-yl] O1-methyl butanedioate tert-butyl N-[4-(7-hydroxy-7-methyl-6,8-dioxoisochromen-3-yl)butyl]carbamate 3-(2-(4-fluorophenyl)-6,8-dimethoxy-1-phenyl-1,2-dihydroisoquinolin-3-yl)oxazolidin-2-one 3-(2-(4-chlorophenyl)-6,8-dimethoxy-1-phenyl-1,2-dihydroisoquinolin-3-yl)oxazolidin-2-one 4-Benzyloxy-2-methoxy-6-methyl-benzoic acid (R)-3-((E)-3-hydroxy-propenyl)-7-methyl-6,8-dioxo-7,8-dihydro-6H-isochromen-7-yl ester (-)-mitorubrinic acid 4-Benzyloxy-2-methoxy-6-methyl-benzoic acid (R)-3-((E)-2-tert-butoxycarbonyl-vinyl)-7-methyl-6,8-dioxo-7,8-dihydro-6H-isochromen-7-yl ester 4-Benzyloxy-2-methoxy-6-methyl-benzoic acid (R)-7-methyl-6,8-dioxo-3-((E)-3-oxo-propenyl)-7,8-dihydro-6H-isochromen-7-yl ester 4-Benzyloxy-2-methoxy-6-methyl-benzoic acid (R)-7-methyl-6,8-dioxo-3-((E)-propenyl)-7,8-dihydro-6H-isochromen-7-yl ester (R)-2-(tert-butoxycarbonyl)-6,8-dimethoxy-1,3-dimethyl-1,2-dihydroisoquinoline (R)-6,8-dimethoxy-2-(methoxycarbonyl)-1,3-dimethyl-1,2-dihydroisoquinoline (R,E)-7-hydroxy-7-methyl-3-(prop-1-en-1-yl)-6H-isochromene-6,8(7H)-dione preasperpyranone 7-butyryloxy-5-chloro-3-(3-hydroxypropyl)-7-methyl-6H-isochromene-6,8-dione Isochromophilone VII Isochromophilone III sclerotiorin 7-epi-sclerotiorin 7-episclerotiorin Sclerotiorin